Hypoxia-regulated lncRNAs in cancer

Gene
Ya-Nan ChangWei Hong

Abstract

Hypoxic regions are common in solid tumors and have an impact on tumor progression and on the therapeutic response. However, the underlying mechanism for hypoxic tumor microenvironment has not been entirely elucidated. Recently, long noncoding RNAs (lncRNAs) are being increasingly recognized to contribute to carcinogenesis through diverse mechanisms. To date, several lncRNAs have been described in hypoxia-associated cancer process, implying a potential role in maintaining cellular homeostasis and enabling an adaptive survival under hypoxic stress conditions. While it has been widely accepted that a complex cellular network of gene products, such as protein and miRNA, take part in hypoxic cancer progression, it remains largely elusive how lncRNAs participate in it. In this review, we introduce an update view of lncRNAs, focusing on hypoxia-related lncRNAs. We hereby summarize the cause and consequence of hypoxia-modulated lncRNAs in cancer as well as their functional mechanisms, highlighting the specific roles of lncRNAs in hypoxia response in cancer.

References

Jan 31, 1995·Proceedings of the National Academy of Sciences of the United States of America·D ShweikiE Keshet
Oct 21, 1993·Nature·Y HaoB Tycko
Jul 6, 2000·The Journal of Biological Chemistry·S RungeJ Christiansen
Feb 22, 2001·Journal of the National Cancer Institute·M Höckel, P Vaupel
Jun 5, 2003·Nature Medicine·Christopher W Pugh, Peter J Ratcliffe
Apr 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Naoki YanagawaTeiichi Motoyama
Sep 29, 2004·Journal of Clinical Pathology·A E Greijer, E van der Wall
Aug 18, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xiao-Song WangWei-Feng Chen
Dec 30, 2006·Molecular and Cellular Biology·Ritu KulshreshthaMircea Ivan
Sep 6, 2007·PloS One·Imad J MatoukEithan Galun
Apr 18, 2008·The Journal of Biological Chemistry·Pasquale FasanaroFabio Martelli
Apr 23, 2008·Proceedings of the National Academy of Sciences of the United States of America·Cecilia SahlgrenUrban Lendahl
Aug 23, 2008·Proceedings of the National Academy of Sciences of the United States of America·Tomomi YoshimizuLuisa Dandolo
Feb 26, 2009·Cell·Chris P PontingWolf Reik
Jul 3, 2009·Genes & Development·Jeremy E WiluszDavid L Spector
Oct 24, 2009·Nucleic Acids Research·Yuki KuwanoMyriam Gorospe
Dec 22, 2009·Current Opinion in Cell Biology·Nathalie M Mazure, Jacques Pouysségur
Feb 2, 2010·Biochimica Et Biophysica Acta·Imad J MatoukAbraham Hochberg
Oct 22, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xin Lu, Yibin Kang
Oct 23, 2010·Molecular Cell·Amar J MajmundarM Celeste Simon
Jul 20, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Fu YangShu-han Sun
Aug 2, 2011·Cell·Leonardo SalmenaPier Paolo Pandolfi
Aug 28, 2012·Trends in Molecular Medicine·Gregg L Semenza
Dec 12, 2012·Journal of Cellular Biochemistry·Yongzhi YangBinghua Jiao
Jan 30, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Man-Tang QiuLin Xu
Sep 17, 2013·Cell Death and Differentiation·J FerdinG A Calin
Jan 8, 2014·Acta Biochimica Et Biophysica Sinica·Xin Huang, Jianhong Zuo
Jan 28, 2014·Journal of Cell Science·Kenji TakahashiTushar Patel

❮ Previous
Next ❯

Citations

Apr 20, 2016·International Journal of Molecular Sciences·Maximilian SelesMartin Pichler
Aug 24, 2016·Frontiers in Physiology·Fredy O Beltrán-AnayaSandra L Romero-Cordoba
Apr 24, 2018·The International Journal of Biological Markers·Eman T ElsayedHaytham M Fayed
Oct 24, 2018·Genes, Chromosomes & Cancer·Yajuan LiChunru Lin
Feb 12, 2019·Cancer Biology & Therapy·Feiyu ChenYibin Feng
Jun 6, 2019·FEBS Letters·Wei XuanDandan Song
Jul 12, 2017·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Kinan Drak Alsibai, Didier Meseure
Aug 10, 2017·Journal of Biomedical Science·Jing-Wen Shih, Hsing-Jien Kung
Jan 19, 2018·International Journal of Oncology·Yujiro NishizawaHideshi Ishii
Aug 22, 2018·Oncology Letters·Bi-Lan Li, Xiao-Ping Wan
Feb 12, 2017·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·C ZhengJ Shao
Mar 15, 2019·Oncology Letters·Zhiqiang YuJianyong Chen
Jun 24, 2017·Nature Communications·Jing-Wen ShihHsing-Jien Kung
Sep 26, 2020·Frontiers in Genetics·Cheng-Yuan SunWei Wang
May 7, 2020·Journal of Biomedical Science·Tse-Chun KuoJing-Wen Shih
May 10, 2020·Molecular Cancer·Yiran LiangQifeng Yang
Jan 8, 2021·Journal of Experimental & Clinical Cancer Research : CR·Jianyong SunLei Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.